Intelligence · Clinical Pipeline
R&D Pipeline Programs
ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.
- Programs indexed
- 20,548
- Companies
- 1,769
- Drugs tracked
- 4,797
Quick answer
NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.
-
Denominación Común Internacional (DCI): placebo (Suero fisiológico) Denominación Química: Cloruro Sódico 0.9% Forma molecular: NaCl Composición cuali y cuantitativa: 9mg/ml Forma farmacéutica: solución para pulverización nasal Dosis y vía de administración: 0.6ml/ día (6 pulverizaciones ) vía intranasa, Syntocinon 40 U.I./ml Solução para pulverização nasal
The George Institute
Borderline Personality Disorder.
1 trial -
Depofoam bupivacaine
Pacira Ireland Limited
Pain, Postoperative
1 trial -
Desipramine
BRIGHT MINDS BIOSCIENCES INC.
Substance-Related Disorders
1 trial -
Desvenlafaxine Succinate
Grace Therapeutics
Vascular Depression
1 trial -
Dexamethasone
The University of Hong Kong
Total Knee Replacement
1 trial -
Dexlansoprazole
Takeda
Gastroesophageal Reflux Disease
4 trials -
Dexlansoprazole 60 MG
Takeda
GERD
1 trial -
Dexmedetomidine
The First People's Hospital of Lianyungang
Postoperative Delirium After Living Donor Renal Transplantation
1 trial -
Digaoxin,amiodarone,β receptor antagonist, Calcium Antagonists
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Atrial Fibrillation
1 trial -
Donepezil
Universal Integrated
Total Knee Arthroplasty
1 trial -
Dronabinol
BRIGHT MINDS BIOSCIENCES INC.
Pregnancy Related
1 trial -
Dual chamber pacemeker
Rhythm Pharmaceuticals Netherlands B.V.
Syncope
1 trial -
Dupilumab, dupilumab placebo, solution for injection in pre-filled syringe
Sanofi-aventis Healthcare Pty Ltd
Asthma
1 trial -
Dupilumab, matched placebo for test product, Ventolin Evohaler 100 micrograms
Sanofi-aventis Healthcare Pty Ltd
Respiratory tract diseases
1 trial -
Dutasteride plus tamsulosin
GlaxoSmithKline
Prostatic Hyperplasia
1 trial -
ELAPRASE
Takeda
Mucopolysaccharidosis (MPS)
1 trial -
ELEVIDYS
Sarepta Therapeutics
Duchenne Muscular Dystrophy
1 trial -
EXPAREL
Pacira Ireland Limited
Pain
4 trials -
EXPAREL
Pacira Ireland Limited
Hip Fractures
1 trial -
EXPAREL
Pacira Ireland Limited
Obesity
1 trial -
EXPAREL
Pacira Ireland Limited
Hernia
1 trial -
EXPAREL
Pacira Ireland Limited
Postoperative Pain
2 trials -
EXPAREL 1.3 % in 20 ML Injection
Pacira Ireland Limited
Rotator Cuff Tear
1 trial -
EXPAREL 20 mL
Pacira Ireland Limited
Postsurgical Pain
1 trial
Frequently asked questions
What is the NovaPharmaNews pipeline directory?
It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.
Where does pipeline data come from?
Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.
How do I find pipeline programs by company or phase?
Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.
Data attribution and licensing: Data sources